Atsuko Ogino

2.1k total citations
18 papers, 917 citations indexed

About

Atsuko Ogino is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Atsuko Ogino has authored 18 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Atsuko Ogino's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). Atsuko Ogino is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). Atsuko Ogino collaborates with scholars based in Japan, United States and United Kingdom. Atsuko Ogino's co-authors include Pasi A. Jänne, Christine Lydon, Katsuyuki Kiura, Mitsune Tanimoto, Mohit Butaney, Lynette M. Sholl, Nagio Takigawa, Bruce E. Johnson, Mizuki Nishino and Jeanne Shen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Atsuko Ogino

17 papers receiving 897 citations

Peers

Atsuko Ogino

PRM

ONCOL

PFM

Junpei Takashima Japan

Erina Hatashita Japan

Kiyoko Kuwata Japan

G. Jeannin France

José Rodrigues Pereira Brazil

Jordi Bertrán-Alamillo Spain

Ken Uchibori Japan

Toshiki Takemoto Japan

Shinnosuke Ikemura Japan

Tzu-Hsiu Chen United States

Junpei Takashima Japan

Atsuko Ogino

718 ×1.1

PRM

604 ×1.1

ONCOL

483 ×1.0

210 ×1.2

104 ×0.8

PFM

Citations per year, relative to Atsuko Ogino Atsuko Ogino (= 1×) peers Junpei Takashima

Countries citing papers authored by Atsuko Ogino

Since Specialization

Citations

This map shows the geographic impact of Atsuko Ogino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Ogino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Ogino more than expected).

Fields of papers citing papers by Atsuko Ogino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Ogino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Ogino. The network helps show where Atsuko Ogino may publish in the future.

Co-authorship network of co-authors of Atsuko Ogino

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Ogino. A scholar is included among the top collaborators of Atsuko Ogino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Ogino. Atsuko Ogino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ogino, Atsuko, Jihyun Choi, Margaret K. Wilkens, et al.. (2020). Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations. Molecular Oncology. 15(1). 27–42. 16 indexed citations

Satō, Hiroshi, et al.. (2019). Ovarian abscess caused by Helicobacter cinaedi in a patient with endometriosis. IDCases. 17. e00578–e00578. 4 indexed citations

Paranal, Raymond M., Michael J. Poitras, Man Xu, et al.. (2019). Abstract 1732: Switch to MET oncogene dependence as a novel mechanism of drug resistance in EGFR-mutant lung cancer. Cancer Research. 79(13_Supplement). 1732–1732. 2 indexed citations

Kosaka, Takayuki, Junko Tanizaki, Raymond M. Paranal, et al.. (2017). Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors. Cancer Research. 77(10). 2712–2721. 100 indexed citations

Xu, Chunxiao, Sharmeen Uddin, Marzia Capelletti, et al.. (2015). Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR -Mutant Lung Cancer. Cancer Discovery. 5(9). 960–971. 159 indexed citations

Cardarella, Stephanie, Atsuko Ogino, Mizuki Nishino, et al.. (2013). Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(16). 4532–4540. 274 indexed citations

Kobayashi, Naruyuki, Shinichi Toyooka, Junichi Soh, et al.. (2011). The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor. Lung Cancer. 75(2). 161–166. 44 indexed citations

Segawa, Yoshihiko, Masanori Fujii, Isao Oze, et al.. (2009). Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications. Journal of Cancer Research and Clinical Oncology. 135(8). 1055–1059. 29 indexed citations

Ichihara, Eiki, Kadoaki Ohashi, Nagio Takigawa, et al.. (2009). Effects of Vandetanib on Lung Adenocarcinoma Cells Harboring Epidermal Growth Factor Receptor T790M Mutation In vivo. Cancer Research. 69(12). 5091–5098. 55 indexed citations

10.

Ogino, Atsuko & Tetsu Shinkai. (2008). [Intrapleural chemotherapy--current status and problems in Japan].. PubMed. 35(6). 896–9.

11.

Toyooka, Shinichi, Akiko Uchida, Hisayuki Shigematsu, et al.. (2007). The Effect of Gefitinib on B-RAF Mutant Non-small Cell Lung Cancer and Transfectants. Journal of Thoracic Oncology. 2(4). 321–324. 2 indexed citations

12.

Uchida, Akiko, Seiki Hirano, Hiroyuki Kitao, et al.. (2007). Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib‐resistance in cells carrying EGFR mutation. Cancer Science. 98(3). 357–363. 41 indexed citations

13.

Ogino, Atsuko, Hiroyuki Kitao, Seiki Hirano, et al.. (2007). Emergence of Epidermal Growth Factor Receptor T790M Mutation during Chronic Exposure to Gefitinib in a Non–Small Cell Lung Cancer Cell Line. Cancer Research. 67(16). 7807–7814. 153 indexed citations

14.

Matsuo, Keitaro, Katsuyuki Kiura, Masahiro Tabata, et al.. (2006). Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non‐small‐cell lung cancer: Experience at a single institution. American Journal of Hematology. 81(5). 349–354. 7 indexed citations

15.

Hotta, Katsuyuki, Hiroshi Ueoka, Katsuyuki Kiura, et al.. (2005). Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group Experience. Acta Oncologica. 44(7). 717–722. 18 indexed citations

16.

Hotta, Katsuyuki, Nagio Takigawa, Katsuyuki Kiura, et al.. (2005). Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.. PubMed. 25(3c). 2429–34. 7 indexed citations

17.

Uchida, Atsushi, Masahiro Tabata, Keitaro Matsuo, et al.. (2005). Incidence of acute promyelocytic leukemia during gefitinib treatment for advanced non-small cell lung cancer. Journal of Clinical Oncology. 23(16_suppl). 7189–7189. 1 indexed citations

18.

Kiura, Katsuyuki, Nagio Takigawa, Akihiro Bessho, et al.. (2005). Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology. 23(16_suppl). 7317–7317. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact